Sun06162019

Robins Global News & Noticias



  • Shipping Advice
    Shipping Advice
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Featured Guest Post
    Featured Guest Post
  • Trump Pence News
    Trump Pence News
  • Weather Alerts
    Weather Alerts

RobinsPost News Network

+ Larger Font | + Smaller Font

Globe NewsWire News Distribution Service

Press Release: BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA


NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today announced that Ralph Kern MD, MHSc, Chief Operating Officer and Chief Medical Officer, will provide a clinical update for the ongoing phase 3 pivotal trial of NurOwn® in ALS patients at the 9th Annual California ALS Research Summit in Irvine, California.
The California ALS Research Summit is an annual meeting of researchers, investigators, clinicians, biotech companies, government representatives, partner organizations, and advocates in ALS and related fields in California.9th Annual California ALS Research Summit Details:Date:                      Friday, January 11, 2019Time:                      2:00-2:30pm Pacific TimeLocation:                Arnold and Mabel Beckman Center of the National Academy of SciencesAgenda:                 https://sites.google.com/a/alsagoldenwest.org/california-als-research-summit/scheduleAbout NurOwn®NurOwn® (autologous MSC-NTF) cells represent a promising investigational therapeutic approach to targeting disease pathways important in neurodegenerative disorders. MSC-NTF cells are produced from autologous, bone marrow-derived mesenchymal stem cells (MSCs) that have been expanded and differentiated ex vivo. MSCs are converted into MSC-NTF cells by growing them under patented conditions that induce the cells to secrete high levels of neurotrophic factors. Autologous MSC-NTF cells can effectively deliver multiple NTFs and immunomodulatory cytokines directly to the site of damage to elicit a desired biological effect and ultimately slow or stabilize disease progression. BrainStorm is currently conducting a Phase 3 pivotal trial of autologous MSC-NTF cells for the treatment of amyotrophic lateral sclerosis (ALS). BrainStorm also recently ...


Posted: 2019-01-11 05:05:00

Get Full News Story On GlobeNewsWire Press Release Service


Listen to this article. Speaker link opens in a new window.
Text To Speech BETA Test Version.


Print Friendly and PDF Share Embed


Related News Stories From The Web And More

Related Bing News

Press Release: BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA | Globe NewsWire News Distribution Service | RobinsPost News Network - Newscast

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 21:31:00 GMT

NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating ...

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 21:06:00 GMT

January 11, 2019 00:05 ET | Source: BrainStorm Cell Therapeutics Inc. NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in ...

BrainStorm to Present NurOwn(R) Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 16:05:00 GMT

NEW YORK and IRVINE, Calif., Jan 11, 2019 (GLOBE NEWSWIRE via COMTEX) -- NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. BCLI, +0.00% a leader in ...

BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA

Thu, 10 Jan 2019 16:00:00 GMT

NEW YORK and IRVINE, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating ...

President Clinton to Deliver Closing Keynote Address on Eliminating Preventable Deaths in Hospitals at the ...

Tue, 10 Jul 2018 05:02:00 GMT

IRVINE, Calif ... leaders and deliver the closing keynote remarks at the 7 th Annual World Patient Safety, Science & Technology Summit, to be held in Huntington Beach, California, on January 18 th and ...

Related Bing Web Search

  • No items found
  • Related News Story Videos From Youtube

    Cordula Dick-Muehlke - MCI Panel: Living with Cognitive Impairment


    Related Videos On: Cordula Dick-Muehlke - MCI Panel: Living with Cognitive Impairment


    Ken Kosik - Clinical Trials: What We've Learned from Colombian Families


    Related Videos On: Ken Kosik - Clinical Trials: What We've Learned from Colombian Families


    The California Experiment in Criminal Justice / Race + Justice


    Related Videos On: The California Experiment in Criminal Justice / Race + Justice


    Panel 1: What Ails California


    Related Videos On: Panel 1: What Ails California


    Dementia and Down Syndrome - Ira T. Lott, MD


    Related Videos On: Dementia and Down Syndrome - Ira T. Lott, MD






    Blow Us A Whistle

    Comments (Whistles) Designed By Disqus




    Company Information

    Official Content Providers











    PRIVACY POLICY

    We recommend Firefox 3 (and above), Edge, and Chrome for dynamic performance.
    © 2008-2019 RobinsPost (The Bird's Eye View Company) All rights are reserved.
    RobinsPost provides links to news sites based on their RSS feeds.
    All trademarks, copyrights, videos, photos and logos are owned by news sources.
    News stories, videos and live streams are from trusted sources:
    Bing News, Google News, Faroo News, NewsApi.org and YouTube Search Results.
    ROBINSPOST Is Proudly Made In America.
    Where Quality, Safety and Service Comes First.